Lung cancer has the highest incidence and mortality rate among malignant tumors, and small cell lung cancer accounts for about 20% of lung cancer, which is the most malignant type of lung cancer with short multiplication time, early and extensive metastasis, sensitive to chemotherapy and radiotherapy, high remission rate of primary treatment, but highly susceptible to secondary drug resistance and easy to relapse. In recent years, experts at home and abroad have been studying the latest chemotherapy regimen combined with radiotherapy to maximize the survival of small cell lung cancer patients, and Global Oncologist Network, as a professional cancer patient service platform that brings together the world’s top anti-cancer technology and top anti-cancer experts, reminds patients that lung cancer is a chronic disease requiring long-term treatment. Modern biomedical science and technology have made continuous breakthroughs and the five-year survival period of patients has been improving. Patients with lung cancer must maintain an optimistic attitude, actively cooperate with doctors and adopt multidisciplinary and comprehensive treatment techniques to overcome cancer. According to Global Oncologist Network, the latest breakthrough anti-cancer technology, A45 treatment technology, has successfully treated a case of advanced small cell lung cancer, which has restored the hope of more lung cancer patients: The patient is a male, 80 years old, diagnosed with small cell lung cancer with mediastinal lymph node metastasis and pleural fluid on July 20, 13. In order to find a better treatment plan, he approached Global Oncologist Network, and after a multidisciplinary expert consultation, the A45 treatment plan was formulated. The two images on the left are the CT and PET-CT images of A45 tumor before treatment, and the two images on the right are the images after treatment. The primary lesions and lymph node metastases basically disappeared, the pleural fluid subsided, and the patient has good quality of life now. According to Global Oncologist Network, A45 treatment technology is another breakthrough anti-cancer technology after surgery, radiotherapy and chemotherapy, which organically combines the world’s top medical gas pedal and photochemotherapy with the advantages of traditional radiation therapy and chemical drug therapy. The treatment effect is greatly enhanced by stimulating the immune response of the body. A45 treatment technology is safe, non-invasive, precise and targeted to remove cancer cells, does not damage normal tissues, has little toxic side effects, and is applicable to almost all cancers. A45 technology has a referral and consultation office in the Global Oncologist Network to assist patients with disease assessment and treatment evaluation. Patients can log on to Global Oncologist Network to communicate with A45 experts online and have online remote consultation. A45 technology has also been introduced by the prestigious Foxchase Cancer Center, one of the leading cancer treatment and research centers in the United States. After the poster exchange at the European Association of Radiology and Oncology Congress held in Italy, the clinical treatment paper “A45 Treatment Mechanism” by Chinese and American experts was selected as Oral presentation at the 58th American Medical Physics Society held in Washington, D.C. in August this year. This marks that A45 clinical anti-cancer research results have been recognized by the international academic community, and it is believed that A45 technology will bring more surprises to cancer patients. Global Oncologist Network is currently holding A45 public benefit consultation activities in collaboration with FCCC Cancer Center China, please visit Global Oncologist Network or call 400-666-7998 for more information.